CardieX Management
Management criteria checks 2/4
CardieX's CEO is Craig Cooper, appointed in Dec 2017, has a tenure of 6.42 years. total yearly compensation is A$1.50M, comprised of 42.2% salary and 57.8% bonuses, including company stock and options. directly owns 2.21% of the company’s shares, worth A$363.69K. The average tenure of the management team and the board of directors is 3.4 years and 5.8 years respectively.
Key information
Craig Cooper
Chief executive officer
AU$1.5m
Total compensation
| CEO salary percentage | 42.2% |
| CEO tenure | 6.4yrs |
| CEO ownership | 2.2% |
| Management average tenure | 3.4yrs |
| Board average tenure | 5.8yrs |
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | -AU$9m |
| Sep 30 2023 | n/a | n/a | -AU$14m |
| Jun 30 2023 | AU$1m | AU$631k | -AU$19m |
| Mar 31 2023 | n/a | n/a | -AU$16m |
| Dec 31 2022 | n/a | n/a | -AU$14m |
| Sep 30 2022 | n/a | n/a | -AU$13m |
| Jun 30 2022 | AU$1m | AU$608k | -AU$12m |
| Mar 31 2022 | n/a | n/a | -AU$11m |
| Dec 31 2021 | n/a | n/a | -AU$10m |
| Sep 30 2021 | n/a | n/a | -AU$7m |
| Jun 30 2021 | AU$1m | AU$529k | -AU$5m |
| Mar 31 2021 | n/a | n/a | -AU$4m |
| Dec 31 2020 | n/a | n/a | -AU$3m |
| Sep 30 2020 | n/a | n/a | -AU$3m |
| Jun 30 2020 | AU$911k | AU$447k | -AU$3m |
| Mar 31 2020 | n/a | n/a | -AU$3m |
| Dec 31 2019 | n/a | n/a | -AU$4m |
| Sep 30 2019 | n/a | n/a | -AU$3m |
| Jun 30 2019 | AU$851k | AU$419k | -AU$3m |
| Mar 31 2019 | n/a | n/a | -AU$3m |
| Dec 31 2018 | n/a | n/a | -AU$3m |
| Sep 30 2018 | n/a | n/a | -AU$3m |
| Jun 30 2018 | AU$392k | AU$226k | -AU$3m |
Compensation vs Market: Craig's total compensation ($USD977.39K) is above average for companies of similar size in the Australian market ($USD292.20K).
Compensation vs Earnings: Craig's compensation has increased whilst the company is unprofitable.
CEO
Craig Cooper (60 yo)
6.4yrs
Tenure
AU$1,495,699
Compensation
Mr. Craig R. Cooper, BEc., LLB (Hons), is the Co-Owner at C2 Ventures Pty Ltd. He is Co-Founder, Group CEO, MD & Executive Director of CardieX Limited. He was Co-Founder, CEO, MD & Executive Director of Ca...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder & Executive Chairman | 6.4yrs | AU$1.02m | 0.66% A$ 108.5k | |
| Co-Founder | 6.4yrs | AU$1.50m | 2.21% A$ 363.7k | |
| Chief Science & Research Officer | no data | AU$240.19k | 0.0084% A$ 1.4k | |
| Chief Medical Officer | 3.4yrs | AU$240.53k | 0% A$ 0 | |
| Chief Product Officer | 3.4yrs | AU$395.47k | 0.038% A$ 6.2k | |
| Chief Strategy Officer | 1.7yrs | AU$385.31k | 0% A$ 0 | |
| Global Head of Marketing & Communications | 4.7yrs | no data | no data | |
| Executive VP & Head of Global Sales for AtCor Medical Division | no data | AU$360.84k | no data | |
| Company Secretary | less than a year | no data | no data |
3.4yrs
Average Tenure
59yo
Average Age
Experienced Management: CDX's management team is considered experienced (3.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder & Executive Chairman | 6.4yrs | AU$1.02m | 0.66% A$ 108.5k | |
| Co-Founder | 6.4yrs | AU$1.50m | 2.21% A$ 363.7k | |
| Independent Non-Executive Director | 8.5yrs | AU$194.65k | 0.0052% A$ 861.6 | |
| Special Advisor | 5.2yrs | no data | no data | |
| Member of Medical Advisory Board | no data | no data | no data | |
| Member of Medical Advisory Board | 1.9yrs | no data | no data | |
| Independent Non-Executive Director | less than a year | no data | no data |
5.8yrs
Average Tenure
60yo
Average Age
Experienced Board: CDX's board of directors are considered experienced (5.8 years average tenure).